Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Procter and Gamble...

    Procter and Gamble gets CCI approval to More than 50 percent pick stake in Merck

    Written by Ruby Khatun Khatun Published On 2018-08-09T17:55:18+05:30  |  Updated On 9 Aug 2018 5:55 PM IST
    Procter and Gamble gets CCI approval to More than 50 percent pick stake in Merck

    New Delhi: The Competition Commission has approved Procter and Gamble's acquisition of 51.80 percent stake in drug firm Merck Ltd, which is listed on the Indian bourses.


    The acquisition of 51.80 per cent stake in Merck Ltd by P&G for nearly Rs 1,290 crore is part of a global deal under which the latter is taking over German firm Merck KGaA's international consumer health business.


    The global deal is for about 3.4 billion euro in cash.


    In a tweet, the Competition Commission of India (CCI) said it has approved an acquisition of 51.80 percent stake by P&G in consumer health business of Merck Ltd.


    The stake acquisition will be through Procter & Gamble Overseas India BV, an investment holding company held ultimately by P&G.


    According to the notice submitted to the CCI, P&G had proposed to acquire the consumer health business of Merck KGaA globally, pursuant to a sale and purchase agreement dated April 19, 2018 (Global SAPA). As part of the agreement, P&G had also offered to buy the consumer health business of Merck Specialities.


    Separately, following another sale and purchase agreement dated April 19, 2018 (India SAPA), Procter & Gamble Overseas India BV had proposed to acquire 51.80 percent shares in Merck Ltd, as per the notice.


    The global deal will be executed through the sale of Merck's shares in a number of legal entities as well as various asset sales and comprises the consumer health business across 44 countries, including more than 900 products and two consumer Health-managed production sites in Spittal (Austria) and Goa (India).


    The transaction is expected to close by the year-end. JP Morgan acted as financial adviser to Merck on the transaction, while Freshfields Bruckhaus Deringer acted as its legal adviser.


    The Competition Commission has also approved Singapore-based investment fund TPG Asia VII SF's stake acquisition in RR Kabel and Ram Ratna Electricals.


    "@CCI_India approves the acquisition of ~21 percent stake in each RR Kabel and Ram Ratna Electricals by TPG Asia," the CCI said in a tweet.


    RR Kabel manufactures wires and cables while Ram Ratna Electricals is the consumer electricals and appliances arm of RR Global Group.

    AcquisitionagreementApprovesCCICompetition Commission of Indiaconsumer health businessMerckMerck LtdP&GProcter and GambleRam RatnaRam Ratna ElectricalsRR KabelstakeTPG Asia
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok